The Acute Ischemic Stroke pipeline presents opportunities with 25+ drugs in development across various stages, emphasizing innovative treatments like Prourokinase recombinant, RNS60, and AVLX-144. Key ...

Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) ...